The TIKR Blog
Sharing actionable investing insights, in-depth stock analysis, and expert tips to help you make smarter investment decisions and think like a business owner.
Latest Posts
Discover our most recent fundamental investing insights.

Is Tempus AI Stock Undervalued With 78% Revenue Growth Projected in 2025?
Tempus AI stock could offer 22% upside over the next two years, driven by rapid revenue growth and strong analyst ratings.

Whirlpool Stock: 9.1% Dividend Yield with 45% Upside Potential Today
The 2-Minute Valuation Model values WHR stock at $110/share in 2 years. That’s a potential 45% upside from today’s price of $76/share.

Why Microsoft (MSFT) Stock Soared 9% Today
Microsoft (MSFT) stock is up more than 9% today after the tech giant crushed Wall Street estimates in fiscal Q3 of 2025.

Should You Buy Medtronic Stock for Its 3.3% Dividend Yield?
The 2-Minute Valuation Model values MDT stock at $102/share in 2 years. That’s a potential 21% upside from today’s price of $84/share.

First Solar (FSLR) Stock Tanks Over 10% Post Q1 Earnings
FSLR stock tumbles after First Solar slashes 2025 guidance, citing tariff uncertainties affecting international operations despite a strong U.S. solar demand outlook.

Why Starbucks (SBUX) Stock Is Down 7% Today
Starbucks stock is down 7% after missing Q2 estimates as turnaround efforts fail to offset rising costs and traffic declines amid tariff concerns.

Why Cadence Design Systems (CDNS) Stock Is Up 4% Today
Cadence Design Systems topped first-quarter estimates and the stock is up 4% in today’s trading. What’s fueling the surge in CDNS stock?

RXRX Stock: Should You Own This Biotech Stock for Its 65% Projected Annual Revenue Growth?
Recursion Pharmaceuticals is expected to disrupt the biotech sector in the upcoming decade. Is RXRX stock a good buy right now?

Novo Nordisk: 60% Upside Potential for this Dividend Growth Giant
Key Takeaways: After a sharp selloff, Novo Nordisk is starting to look like an attractive opportunity for long-term investors. The industry leader now offers its highest dividend yield in five years, while its core pharmaceutical business in diabetes and obesity treatments continues to drive solid growth. With analy

Why NXP Semiconductors (NXPI) Stock Is Down Almost 9% Today
NXPI stock is down almost 40% from all-time highs after its CEO announced his resignation during the Q1 earnings call.

How to Track Insider Trading in Stocks and See What Insiders are Buying
If you want to know where the smart money is going, it can be helpful to watch the people who run the business. Insider buying can reveal when executives believe their own stock is too cheap to ignore. When insiders buy a stock, they often have access to information, experience, or conviction that the average …
Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.